AUPH - Aurinia Pharmaceuticals Inc. (AUPH) CEO John Leonard on Q2 2021 Results - Earnings Call Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President of Corporate Communications & Investor Relations Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial Officer Max Colao - Chief Commercial Officer Neil Solomons - Chief Medical Officer Conference Call Participants Justin Kim - Oppenheimer Ken Cacciatore - Cowen & Company David Martin - Bloom Burton Presentation Operator Hello and welcome to the Aurinia Pharmaceuticals' Second Quarter Earnings Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Glenn Schulman, Head of Investor Relations. Please, go ahead. Glenn Schulman Thanks, Kevin, and thanks to all for joining us today as we discuss Aurinia's

For further details see:

Aurinia Pharmaceuticals Inc. (AUPH) CEO John Leonard on Q2 2021 Results - Earnings Call Transcript